MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral ...

Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study evaluating its drug candidate ART27.13 for the treatment of glaucoma. The San ...

LAKE ZURICH, IL, UNITED STATES, March 17, 2026 /EINPresswire.com/ -- The Sikh community in the United States, estimated ...

"This is changing the way we practice prostate cancer." ...

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

Residual gastric volume precluded endoscopic examination ...

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ...

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...

Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.

PhaseWell Research ("PhaseWell"), a multisite clinical research company, today announced the strategic acquisition of Chase ...